Abstract
Transposable elements (TEs) are dynamically expressed at high levels in multiple human tissues, but the function of TE-derived transcripts remains largely unknown. In this study, we identify numerous TE-derived microRNAs (miRNAs) by conducting Argonaute2 RNA immunoprecipitation followed by small RNA sequencing (AGO2 RIP-seq) on human brain tissue. Many of these miRNAs originated from LINE-2 (L2) elements, which entered the human genome around 100-300 million years ago. L2-miRNAs derived from the 3' end of the L2 consensus sequence and thus shared very similar sequences, indicating that L2-miRNAs could target transcripts with L2s in their 3'UTR. In line with this, many protein-coding genes carried fragments of L2-derived sequences in their 3'UTR: these sequences served as target sites for L2-miRNAs. L2-miRNAs and their targets were generally ubiquitously expressed at low levels in multiple human tissues, suggesting a role for this network in buffering transcriptional levels of housekeeping genes. In addition, we also found evidence that this network is perturbed in glioblastoma. In summary, our findings uncover a TE-based post-transcriptional network that shapes transcriptional regulation in human cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
3' Untranslated Regions
-
Animals
-
Argonaute Proteins / genetics
-
Argonaute Proteins / metabolism
-
Base Sequence
-
Brain / metabolism
-
Brain Neoplasms / genetics
-
Brain Neoplasms / metabolism
-
DNA Transposable Elements*
-
Gene Expression Regulation
-
Gene Regulatory Networks
-
Genome, Human
-
Glioblastoma / genetics
-
Glioblastoma / metabolism
-
Humans
-
Long Interspersed Nucleotide Elements*
-
Mice
-
MicroRNAs / genetics*
-
MicroRNAs / metabolism
Substances
-
3' Untranslated Regions
-
AGO2 protein, human
-
Argonaute Proteins
-
DNA Transposable Elements
-
MicroRNAs
Grants and funding
The study was supported by the Swedish Research Council ([http://]
www.vr.se; JJ, 521-2013-3342), the Swedish Foundation for Strategic Research (JJ, FFL12-074), the Swedish Cancer Foundation ([http://]
www.cancerfonden.se; JJ, 180320), the Swedish Childhood Cancer Foundation (
www.barncancerfonden.se; JJ, PR2017-0053), Hjärnfonden ([http://]
www.hjarnfonden.se; JJ, FO2018-0183), the Swedish excellence project Basal Ganglia Disorders Linnaeus Consortium (Bagadilico) and the Swedish Government Initiative for Strategic Research Areas (MultiPark & StemTherapy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.